Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Catto

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|April 1, 1997
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular diseaseA J Catto, A M Carter, M Stickland, et al.
Thrombosis and Haemostasis|October 6, 1998
Prevalence of FXIII V34L in populations with different cardiovascular riskL J McCormack, K Kain, A J Catto, et al.
Blood|July 27, 2000
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolismA M Carter, A J Catto, H P Kohler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromesA Hassan, A Lansbury, A J Catto, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosisN Komanasin, A J Catto, T S Futers, et al.
Acta Neurologica Scandinavica|July 6, 2000
Apolipoprotein E polymorphism in cerebrovascular diseaseA J Catto, L J McCormack, M W Mansfield, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
Plasma angiotensin-converting enzyme in Alzheimer's diseaseEmma R L C Vardy, Penny J Rice, Peter C W Bowie, et al.
Cancer Epidemiology|September 13, 2011
A comparison of prostate cancer survival in England, Norway and Sweden: a population-based studyL Holmberg, D Robinson, F Sandin, et al.
British Journal of Cancer|June 20, 2013
Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancerC Blick, A Ramachandran, S Wigfield, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]M Burger, J Catto, J van Oers, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|April 1, 1997
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular diseaseA J Catto, A M Carter, M Stickland, et al.
Thrombosis and Haemostasis|October 6, 1998
Prevalence of FXIII V34L in populations with different cardiovascular riskL J McCormack, K Kain, A J Catto, et al.
Blood|July 27, 2000
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolismA M Carter, A J Catto, H P Kohler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromesA Hassan, A Lansbury, A J Catto, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosisN Komanasin, A J Catto, T S Futers, et al.
Acta Neurologica Scandinavica|July 6, 2000
Apolipoprotein E polymorphism in cerebrovascular diseaseA J Catto, L J McCormack, M W Mansfield, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
Plasma angiotensin-converting enzyme in Alzheimer's diseaseEmma R L C Vardy, Penny J Rice, Peter C W Bowie, et al.
Cancer Epidemiology|September 13, 2011
A comparison of prostate cancer survival in England, Norway and Sweden: a population-based studyL Holmberg, D Robinson, F Sandin, et al.
British Journal of Cancer|June 20, 2013
Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancerC Blick, A Ramachandran, S Wigfield, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]M Burger, J Catto, J van Oers, et al.
Pageof 6